Viscosupplementation Market Regional Analysis, Key Players, Opportunities and Forecast to 2030

Viscosupplementation Market

The viscosupplementation market is anticipated to reach USD 4,760 Million by 2030 at 11.32% CAGR during the forecast period 2022-2030

Market Research Future (MRFR) discusses the market and considers the time frame as the forecast period. Viscosupplementation can be defined as a process that requires physicians to inject a lubricating fluid-like hyaluronic acid (HA) injection or hyaluronan injection into a joint as an attempt to treat symptoms various forms of osteoarthritis like knee, hip, shoulder, ankle, and spine arthritis. Increasing demand for minimally-invasive surgeries can make sure that the market gains a better growth rate and fetches good revenues.

Among other features, initiatives taken by various investors, rising cases of obesity, diabetes, hypertension, renal failure, gastrointestinal bleeding, cardiovascular diseases, depression, disability in the geriatric population can trigger a hike in the growth rate of the viscosupplementation market. Women are more prone to this disease. Other things like lifestyle changes can also impact market growth. Various cases like smoking, poor nutrition, injuries, and others can influence market growth as well.

Major Key Players:

MRFR in its expert analysis of the global viscosupplementation market players included companies that have initiated changes in the market with an aim to impact its growth. These companies are Hoffmann-La Roche, Sanofi, Allergan, Anika Therapeutics Inc., Bioventus, Regen Lab SA, Zimmer Biomet, Smith & Nephew Plc, Ferring B.V., Fidia Farmaceutici S.P.A., and others.

Segment Analysis

The global viscosupplementation market includes segments like hyaluronic acid type, procedure type, application, and end-user to facilitate an easy understanding of the market. This method provides a closer look at the market that can ensure better growth in the coming years.

By hyaluronic acid type, the global market report for the viscosupplementation market includes stabilized hyaluronic acid and standard hyaluronic acid. The stabilized hyaluronic acid segment has the largest market share as its impurity level is close to zero.

By procedure type, the market report on the viscosupplementation market comprises three-injection procedure, single-injection procedure, and five-injection procedure. The three-injection procedure segment has a better opportunity to maintain its robust growth as it is lower in price when compared with the single-injection procedures and takes less time than the five-injection procedure. Its CAGR could cross a valuation of USD 2602.58 million during the forecast period.

By application, the market report covering the viscosupplementation market includes knee arthritis and hip osteoarthritis. The knee arthritis segment has a better market share than hip osteoarthritis.

By end user, the market report can be segmented into hospitals & clinics and ambulatory surgical centers. The hospitals & clinics segment has a larger share owing to people preferring this setup for their treatment.

Regional Analysis

The Americas stood at the top in 2017 and has the opportunity to score the highest CAGR in the coming years. The demand for knee replacement surgeries with increasing thrust from the minimally-invasive procedures can trigger the growth of viscosupplementation procedures.

The Asia-Pacific region has the second-largest market share and can score well-past USD 447.24 million valuations by 2023 with a CAGR of 10.48% during the forecast period. The region would witness contributions made by countries like China, India, and others. These are countries with high expenditure capacity and huge patient pool. In Europe, the growth would be the most in the UK, where increased awareness regarding the procedure would trigger better growth.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Also Check: Wantstats charts and Stats

Comments

Post a Comment

Popular posts from this blog

Medical Image Management Market: An Extensive Examination of Market Size, Key Players, and Emerging Opportunities

The   Medical Image Management Market   to be estimated around USD 109 Billion at a CAGR of around 8% till 2032. The Medical Image Management market has witnessed significant growth in recent years, driven by the increasing demand for advanced healthcare solutions and the rapid adoption of digital imaging technologies. The convergence of medical image analysis software and medical imaging has played a pivotal role in reshaping the landscape of medical diagnostics and patient care. Medical image analysis software  has emerged as a critical component in the field of healthcare, offering innovative tools for interpreting and processing medical images. These software solutions enable healthcare professionals to extract valuable insights from various imaging modalities, including X-rays, MRIs, CT scans, and ultrasound. The integration of artificial intelligence (AI) and machine learning algorithms in medical image analysis software has further enhanced the accuracy and efficie...
Read more

Durable Medical Equipment Market Size: Trends, Challenges, and Future Outlook

The   Durable Medical Equipment Market   is projected to reach USD 304 billion by 2032 at 4.7 % CAGR during the forecast period 2023-2032. The Durable Medical Equipment (DME) market is a critical component of the healthcare industry, encompassing a wide range of products designed to provide therapeutic benefits and assist patients with various medical conditions. DME includes durable and reusable medical devices prescribed by healthcare professionals to improve patients' quality of life and enhance their mobility. Key drivers of the Durable Medical Equipment market include an aging population, increasing prevalence of chronic diseases, and advancements in medical technology. As the global population continues to age, the demand for DME such as mobility aids, respiratory devices, and home care equipment is on the rise. This trend is further fueled by the growing emphasis on home-based healthcare solutions, fostering independence among patients and reducing the burden on traditi...
Read more

Revolutionizing Genomics: The Growing Landscape of DNA Sequencing Market

DNA sequencing stands at the forefront, unlocking the secrets of life encoded within our genetic makeup. The DNA sequencing market has witnessed remarkable growth, fueled by advancements in technology and a deepening understanding of the human genome. Genetic sequencing and genome sequencing have become pivotal tools, revolutionizing fields such as personalized medicine, agriculture, and evolutionary biology. DNA Sequencing Market Size is projected to grow from USD 2.5 Billion in 2023 to USD 4.8 billion by 2030, at CAGR 11.20% during the forecast period (2023 - 2030) Genetic sequencing, a fundamental aspect of DNA analysis, involves the determination of the order of nucleotides in a DNA molecule. This process allows scientists to decipher the genetic code, providing insights into the genetic variations that contribute to an individual's unique traits and susceptibility to certain diseases. As technology has evolved, the cost of genetic sequencing has significantly decreased, ...
Read more